Your search returned 11 results.

Results
	1.	Sensitive substrates for neprilysin (neutral endopeptidase) and thermolysin that are highly resistant to serine proteases. [electronic resource] by Spungin-Bialik, A Ben-Meir, D Fudim, E Carmeli, S Blumberg, S Producer: 19960515 In: FEBS letters vol. 380 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Renal effects of 2-mercaptoacetyl-L-leucyl-L-phenylalanine, a novel selective inhibitor of neutral endopeptidase 24.11 (Neprilysin): comparison with SQ 28,603. [electronic resource] by Gurbanov, K Shuranyi, E Kaballa, A Fudim, E Blumberg, S Winaver, J Producer: 19991019 In: General pharmacology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation. [electronic resource] by Lahat, A Ben-Horin, S Horin, S B Lang, A Fudim, E Picard, O Chowers, Y Producer: 20080604 In: Clinical and experimental immunology vol. 152 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Soluble Syndecan-1: A Novel Biomarker of Small Bowel Mucosal Damage in Children with Celiac Disease. [electronic resource] by Yablecovitch, D Oren, A Ben-Horin, S Fudim, E Eliakim, R Saker, T Konikoff, F M Kopylov, U Matthias, T Lerner, A Producer: 20170713 In: Digestive diseases and sciences vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Early preservation of effector functions followed by eventual T cell memory depletion: a model for the delayed onset of the effect of thiopurines. [electronic resource] by Ben-Horin, S Goldstein, I Fudim, E Picard, O Yerushalmi, Z Barshack, I Bank, I Goldschmid, Y Meir, S Bar Mayer, L Chowers, Y Producer: 20090318 In: Gut vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Inhibition of Streptomyces griseus aminopeptidase and effects of calcium ions on catalysis and binding--comparisons with the homologous enzyme Aeromonas proteolytica aminopeptidase. [electronic resource] by Papir, G Spungin-Bialik, A Ben-Meir, D Fudim, E Gilboa, R Greenblatt, H M Shoham, G Lessel, U Schomburg, D Ashkenazi, R Blumberg, S Producer: 19990128 In: European journal of biochemistry vol. 258 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy. [electronic resource] by Bar-Yoseph, H Levhar, N Selinger, L Manor, U Yavzori, M Picard, O Fudim, E Kopylov, U Eliakim, R Ben-Horin, S Chowers, Y Ungar, B Producer: 20180521 In: Alimentary pharmacology & therapeutics vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Safety, efficacy and pharmacokinetics of vedolizumab in patients with simultaneous exposure to an anti-tumour necrosis factor. [electronic resource] by Ben-Horin, S Ungar, B Kopylov, U Lahat, A Yavzori, M Fudim, E Picard, O Peled, Y Eliakim, R Del Tedesco, E Paul, S Roblin, X Producer: 20190603 In: Alimentary pharmacology & therapeutics vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	The decline of anti-drug antibody titres after discontinuation of anti-TNFs: implications for predicting re-induction outcome in IBD. [electronic resource] by Ben-Horin, S Mazor, Y Yanai, H Ron, Y Kopylov, U Yavzori, M Picard, O Fudim, E Maor, Y Lahat, A Coscas, D Eliakim, R Dotan, I Chowers, Y Producer: 20120529 In: Alimentary pharmacology & therapeutics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Addition of an immunomodulator can reverse antibody formation and loss of response in patients treated with adalimumab. [electronic resource] by Ungar, B Kopylov, U Engel, T Yavzori, M Fudim, E Picard, O Lang, A Williet, N Paul, S Chowers, Y Bar-Gil Shitrit, A Eliakim, R Ben-Horin, S Roblin, X Producer: 20170829 In: Alimentary pharmacology & therapeutics vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Induction infliximab levels among patients with acute severe ulcerative colitis compared with patients with moderately severe ulcerative colitis. [electronic resource] by Ungar, B Mazor, Y Weisshof, R Yanai, H Ron, Y Goren, I Waizbard, A Yavzori, M Fudim, E Picard, O Loebstein, R Kopylov, U Dotan, I Chowers, Y Eliakim, R Ben-Horin, S Producer: 20170815 In: Alimentary pharmacology & therapeutics vol. 43 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)